Metformin may reduce food intake and body weight, but the anorexigenic effects of metformin are still poorly understood. Under normal physiological conditions, Prof. Zheng Zhao and his team from the Key Laboratory of Brain Functional Genomics, Ministry of Education, China observed the changes in food intake after administration of metformin. They found that the central administration of metformin significantly reduced food intake and body weight gain, and a reduction of neuropeptide Y expression and induction of AMP-activated protein kinase phosphorylation in the hypothalamus were also observed, which could be reversed by compound C, a commonly-used antagonist of AMP-activated protein kinase. Furthermore, metformin also improved lipid metabolism by reducing plasma low-density lipoprotein. These findings were published in the Neural Regeneration Research (Vol. 8, No. 25, 2013).
Article: " Metformin inhibits food intake and neuropeptide Y gene expression in the hypothalamus " by Yale Duan1, Rui Zhang1, Min Zhang2, Lijuan Sun1, Suzhen Dong1, Gang Wang2, Jun Zhang2, Zheng Zhao1 (1 Key Laboratory of Brain Functional Genomics, Ministry of Education, Shanghai Key Laboratory of Brain Functional Genomics, East China Normal University, Shanghai 200062, China; 2 Department of Clinical Laboratory, Shanghai Public Health Clinical Center Affiliated to Fudan University, Shanghai 201508, China)
Duan YL, Zhang R, Zhang M, Sun LJ, Dong SZ, Wang G, Zhang J, Zhao Z. Metformin inhibits food intake and neuropeptide Y gene expression in the hypothalamus. Neural Regen Res. 2013;8(25):2379-2388.
Contact: Meng Zhao
Neural Regeneration Research
Full text: http://www.sjzsyj.org/CN/article/downloadArticleFile.do?attachType=PDF&id=711
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.